ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform
CARLSBAD, Calif., Nov. 2, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) reached a milestone of 500,000 patient tests performed with the SOZO® Digital Health Platform. With over 1,100 devices in ...
BRISBANE, Australia and CARLSBAD, Calif., July 15, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce that two abstracts evaluating use of ImpediMed's SOZO ® Digital Health ...
Bioimpedance Spectroscopy Distinguishes between Fluid Status in Individuals with and without Heart Failure Bioimpedance Spectroscopy Derived Arm-to-Leg R0_ratio as a Predictor of Increased ...
CARLSBAD, Calif. & BRISBANE, Australia--(BUSINESS WIRE)--ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid ...
New round will help fuel commercialization efforts in support of ImpediMed's platform technology for the detection and monitoring of lymphedema. With this new funding in place, ImpediMed's capital ...
Bioimpedance Spectroscopy Distinguishes between Fluid Status in Individuals with and without Heart Failure Bioimpedance Spectroscopy Derived Arm-to-Leg R0_ratio as a Predictor of Increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback